Literature DB >> 31056724

Reintegrating Employees Undergoing Cancer Treatment into the Workplace: A Qualitative Study of Employer and Co-worker Perspectives.

K S Petersen1, A H Momsen2, C M Stapelfeldt2, C V Nielsen2.   

Abstract

Purpose The purpose of this study was to explore how employers and co-workers experience the return to work (RTW) process of employees undergoing cancer treatment. Methods Sixteen semi-structured individual interviews and participant observations at seven workplaces took place, involving seven employers and nine co-workers with different professions. A phenomenological-hermeneutic analytic approach was applied involving coding, identification of themes, and interpretation. Results We identified three employer themes: call for knowledge, Making decisions, and Feeling helpless. Also, three co-worker themes were identified: understanding and sympathy, extra work and burden, and Insecurity about future work tasks. Early initiated RTW, e.g. less work hours and work accommodations, did neither constitute challenges for employers nor co-workers in the beginning of the RTW process. However, when the RTW process was prolonged employers encountered difficulties in finding suitable work tasks, whereas co-workers were burdened by extra work. Conclusions Overall, cancer survivors' RTW process was welcomed and encouraged at the workplace level. However, employer and co-worker experiences suggested that RTW initiation parallel with cancer treatment raised challenges at the workplace level, when the RTW process was extended beyond the initial RTW plan; increased workload and difficulties in balancing the needs of the cancer survivor and co-workers. Mechanisms that support cancer survivors' RTW without introducing strain on co-workers should be investigated in future research. Furthermore, support for employers in their RTW management responsibilities needs to be addressed in general and in particular in future RTW interventions.

Entities:  

Keywords:  Cancer survivors; Rehabilitation; Return to work; Workplace

Mesh:

Year:  2019        PMID: 31056724     DOI: 10.1007/s10926-019-09838-1

Source DB:  PubMed          Journal:  J Occup Rehabil        ISSN: 1053-0487


  24 in total

1.  Employee to employer communication skills: balancing cancer treatment and employment.

Authors:  Richard F Brown; Myra Owens; Cathy Bradley
Journal:  Psychooncology       Date:  2011-12-12       Impact factor: 3.894

2.  Three approaches to qualitative content analysis.

Authors:  Hsiu-Fang Hsieh; Sarah E Shannon
Journal:  Qual Health Res       Date:  2005-11

Review 3.  Systematic review of the qualitative literature on return to work after injury.

Authors:  Ellen MacEachen; Judy Clarke; Renée-Louise Franche; Emma Irvin
Journal:  Scand J Work Environ Health       Date:  2006-08       Impact factor: 5.024

4.  Return to work after cancer in the UK: attitudes and experiences of line managers.

Authors:  Ziv Amir; Phil Wynn; Fong Chan; David Strauser; Stuart Whitaker; Karen Luker
Journal:  J Occup Rehabil       Date:  2010-12

5.  Return-to-work intervention during cancer treatment - The providers' experiences.

Authors:  K S Petersen; A H Momsen; C M Stapelfeldt; P R Olsen; C V Nielsen
Journal:  Eur J Cancer Care (Engl)       Date:  2017-12-04       Impact factor: 2.520

6.  Health Care Professionals and the Employment-Related Needs of Cancer Survivors.

Authors:  Kathleen M Murphy; Vinh Nguyen; Ki Shin; Amy Sebastian-Deutsch; Lex Frieden
Journal:  J Occup Rehabil       Date:  2017-06

7.  The use of the ICF to describe work related factors influencing the health of employees.

Authors:  Yvonne Heerkens; Josephine Engels; Chris Kuiper; Joost Van der Gulden; Rob Oostendorp
Journal:  Disabil Rehabil       Date:  2004-09-02       Impact factor: 3.033

8.  Cancer survivors and unemployment: a meta-analysis and meta-regression.

Authors:  Angela G E M de Boer; Taina Taskila; Anneli Ojajärvi; Frank J H van Dijk; Jos H A M Verbeek
Journal:  JAMA       Date:  2009-02-18       Impact factor: 56.272

Review 9.  Employment challenges for cancer survivors.

Authors:  Anja Mehnert; Angela de Boer; Michael Feuerstein
Journal:  Cancer       Date:  2013-06-01       Impact factor: 6.860

10.  The provision of workplace accommodations following cancer: survivor, provider, and employer perspectives.

Authors:  Mary Stergiou-Kita; Cheryl Pritlove; Dwayne van Eerd; Linn D Holness; Bonnie Kirsh; Andrea Duncan; Jennifer Jones
Journal:  J Cancer Surviv       Date:  2015-10-31       Impact factor: 4.442

View more
  5 in total

1.  Exploring Employer Perspectives on Their Supportive Role in Accommodating Workers with Disabilities to Promote Sustainable RTW: A Qualitative Study.

Authors:  J Jansen; C R L Boot; M A Alma; S Brouwer
Journal:  J Occup Rehabil       Date:  2022-02-15

2.  Supporting employers to enhance the return to work of cancer survivors: development of a web-based intervention (MiLES intervention).

Authors:  M A Greidanus; A G E M de Boer; C M Tiedtke; M H W Frings-Dresen; A E de Rijk; S J Tamminga
Journal:  J Cancer Surviv       Date:  2020-01-14       Impact factor: 4.442

3.  "The Last Thing You Have to Worry About": A Thematic Analysis of Employment Challenges Faced by Cancer Survivors.

Authors:  Kathleen Doyle Lyons; Rachel C Forcino; Sivan Rotenberg; Jenna E Schiffelbein; Kali J Morrissette; Cassandra M Godzik; Jonathan D Lichtenstein
Journal:  Int J Environ Res Public Health       Date:  2022-09-07       Impact factor: 4.614

4.  The Use and Perceived Usefulness of an Online Toolbox Targeted at Employers (MiLES Intervention) for Enhancing Successful Return to Work of Cancer Survivors.

Authors:  M A Greidanus; A E de Rijk; M H W Frings-Dresen; C M Tiedtke; S Brouwers; A G E M de Boer; S J Tamminga
Journal:  J Occup Rehabil       Date:  2021-06

5.  A randomised feasibility trial of an employer-based intervention for enhancing successful return to work of cancer survivors (MiLES intervention).

Authors:  M A Greidanus; A E de Rijk; A G E M de Boer; M E M M Bos; P W Plaisier; R M Smeenk; M H W Frings-Dresen; S J Tamminga
Journal:  BMC Public Health       Date:  2021-07-21       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.